Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fort Mason Capital is a private investment firm based in San Francisco, California, that specializes in the life sciences, biotechnology, and healthcare sectors. The firm is primarily known for providing growth capital to early- and mid-stage companies through various financing structures, including venture capital rounds and Private Investment in Public Equity (PIPE) transactions. Founded by Nicholas J. Pritzker and Joseph J. Scalzo, Fort Mason Capital has a history of supporting innovative therapeutic developers and medical technology firms. While it operates as a financial entity rather than a drug developer, its portfolio has included significant stakes in clinical-stage biopharmaceutical companies such as Abeona Therapeutics and Relief Therapeutics. The firm's investment strategy focuses on identifying high-potential medical innovations and providing the strategic capital necessary to advance them through critical clinical milestones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fort Mason Capital.